TLDR: Salesforce (CRM) stock declined by approximately 3% on September 30, 2025, following a weaker-than-expected Q3 revenue guidance. This downturn has intensified investor scrutiny over the company’s ambitious artificial intelligence (AI) initiatives and its ability to monetize them effectively amidst a challenging enterprise spending environment. Despite beating Q2 earnings estimates, the conservative forecast for the upcoming quarter, coupled with broader software sector jitters, has led to a re-evaluation of Salesforce’s growth trajectory.
On September 30, 2025, Salesforce (NYSE: CRM) shares closed around $237.41, marking a decline of approximately 3.1% for the day. This drop follows a period of volatile trading, with the stock having been in the mid-$240s earlier in the week. Year-to-date, CRM remains below its early September highs of around $258, as investors grapple with slower enterprise spending and concerns regarding AI integration.
The recent downturn was primarily triggered by Salesforce’s Q3 FY2026 revenue guidance, which came in below Wall Street expectations. While the company reported solid Q2 FY2026 results with $10.24 billion in revenue (up approximately 10% year-over-year) and adjusted earnings of $2.91 per share (beating analyst estimates of $2.78), its forecast for Q3 revenue between $10.24 billion and $10.29 billion disappointed investors. This cautious outlook for the upcoming quarter, particularly signaling slower growth in marketing and commerce segments, led to a sharp decline in shares, including a roughly 7% drop in after-hours trading on September 4.
Salesforce’s significant investments and ambitions in artificial intelligence are under the spotlight. The company announced a $6 billion investment in UK AI initiatives through 2030 on September 16, underscoring its commitment to AI. Its “Winter ’26” product release on September 8 featured new AI/data enhancements like Agentforce IT service and Agentforce Grid. AI initiatives, such as Data Cloud, have driven substantial growth, with a 120% increase in Annual Recurring Revenue (ARR). However, investor skepticism persists regarding the company’s ability to effectively monetize these AI advancements and sustain growth in an “AI-driven software landscape” where competitors like Microsoft are also navigating integration challenges. Debates around AI monetization are a key factor influencing investor caution.
Analysts generally maintain a “Moderate Buy” consensus rating for CRM, with a one-year average price target of approximately $333, suggesting a potential 40% upside. However, price targets vary widely, from $221 to $405, reflecting differing views on AI growth versus integration hurdles. For instance, Morgan Stanley raised its target to $405, while UBS cut its target to $260, citing concerns about the slow integration of the Informatica deal. Goldman Sachs maintains a $385 target, highlighting 120% growth in its Data Cloud and 6,000 paid AI deals. Market strategists advise investors to remain patient with Salesforce’s AI investments. Technically, the stock is trading near its 50-day moving average but below its 100- and 200-day averages, with the 14-day RSI being neutral. Institutional selling pressure has been noted over the past 13 weeks, suggesting large investors may be reducing their positions.
Also Read:
- C3.ai’s Strategic Positioning in the Expanding Global Generative AI Market
- OpenAI Achieves $4.3 Billion First-Half Revenue Amid Surging AI Demand
Other developments include Salesforce’s pending $8 billion acquisition of Informatica, which has added to short-term uncertainty. Additionally, CEO Marc Benioff’s insider stock sales in mid-to-late September (around 2,250 shares/day at $242–$251) are being watched by some investors as a potential contrarian signal. The company also faced security-related news, with several major customers affected by cyber-attacks, leading to 14 lawsuits filed against Salesforce in September over platform breaches. Despite these challenges, Salesforce remains the dominant CRM vendor.
